Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations

Journal of Molecular Modeling

Volumn 18, Issue 2, 2012, Pages 755-764

  Vianna, Carolina Pasa ^a   De Azevedo Jr , Walter F ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Molecular docking; Shikimate kinase; Shikimate pathway; Tuberculosis; Virtual screening

Indexed keywords

SHIKIMIC ACID;

ARTICLE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; CRYSTALLOGRAPHY; LIGAND BINDING; MOLECULAR DOCKING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUBERCULOSIS;

ALGORITHMS; ANTITUBERCULAR AGENTS; BINDING SITES; COMPUTER SIMULATION; HUMANS; LIGANDS; MODELS, MOLECULAR; MYCOBACTERIUM TUBERCULOSIS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTEIN STRUCTURE, SECONDARY;

MAMMALIA; MYCOBACTERIUM TUBERCULOSIS;

EID: 84861231361     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-011-1113-5     Document Type: Article

References (36)

1. World Health Organization (2009) WHO Report. Geneva. Switzerland. WHO/CDS/TB/2009. http://www.who.int/topics/tuberculosis/ en/. Accessed in October 2010
2. Basso LA, Pereira Da Silva LH, Fett-Neto AG, De Azevedo Jr WF, Moreira IS, Palma MS, Calixto JB, Astolfi Filho S, dos Santos RR, Soares MBP, Santos DS (2005) Mem Inst Oswaldo Cruz 100:475-506
3. Davies GM, Barrett-Bee KJ, Jude DA, Lehan M, Nichols WW, Pinder PE, Thain JL, Watkins WJ, Wilson RG (1994) Antimicrob Agents Chemother 38:403-406
4. Coggins JR (1989) The shikimate pathway as a target for herbicides. In: Dodge AD (ed) Herbicides and Plant metabolism. Cambridge University Press, Cambridge, UK, pp 97-112
5. Bentley R (1990) The shikimate pathway-a metabolic tree with many branches. Crit Rev Biochem Mol Biol 25:307-384 (Pubitemid 120012279)
6. Ratledge C (1982) Nutrition, growth and metabolism. In: Ratledge C, Stanford JL (eds) The Biology of the Mycobacteria, vol 1. Academic, London, pp 185-271
7. Krell T, Coggins JR, Lapthorn AJ (1998) The three-dimensional structure of shikimate kinase. J Mol Biol 278:983-997 (Pubitemid 28239699)
8. Pereira JH, Oliveira JS, Canduri F, Dias MVB, Palma MS, Basso LA, Santos DS, De Azevedo Jr WF (2004) Acta Crystallogr D Biol Crystallogr 60:2310-2319
9. Parish T, Stoker NG (2002) The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis. Microbiology 148:3069-3077 (Pubitemid 35243706)
10. Vonrhein C, Schlauderer GJ, Schulz GE (1995) Movie of the structural changes during a catalytic cycle of nucleoside monophosphate kinases. Structure 3:483-490
11. Gu Y, Reshetnikova L, Li Y, Wu Y, Yan H, Singh S, Ji X (2002) Crystal structure of shikimate kinase from mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis. J Mol Biol 319:779-789 (Pubitemid 34729450)
12. Peitsch MC (2004) Manuel Peitsch discusses knowledge management and informatics in drug discovery. Drug Discov Today Biocilico 02:94-96
13. Dias MV, Vasconcelos IB, Prado AM, Fadel V, Basso LA, De Azevedo Jr WF, Santos DS (2007) Acta Crystallogr F Struct Biol Cryst Commun 63:1-6
14. Thomsen R, Christensen MH (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 11:3315-3321 (Pubitemid 43830529)
15. De Azevedo Jr WF, Canduri F, Da Silveira NJF (2002) Biochem Biophys Res Commun 293:566-571
16. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shaw DE, Shelley M, Perry JK, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739-1749 (Pubitemid 38380917)
17. Thilagavathi R, Mancera RL (2010) Ligand-protein cross-docking with water molecules. J Chem Inf Model 50:415-421
18. Irwin JJ, Shoichet BK (2005) ZINC - a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177-182 (Pubitemid 40736970)
19. Timmers LFS, Pauli I, Caceres RA, De Azevedo Jr WF (2008) Drug-binding databases. Curr Drug Targets 9:1092-1099
20. De Azevedo Jr WF (2010) Structure-based virtual screening. Curr Drug Targets 11:261-263
21. De Azevedo Jr WF (2010) MolDock applied to structure-based virtual screening. Curr Drug Targets 11:327-334
22. Yang JM (2004) Development and evaluation of a generic evolutionary method for protein-ligand docking. J Comput Chem 25:843-857
23. Yang JM, Chen CC (2004) GEMDOCK: a generic evolutionary method for molecular docking. Proteins 55:288-304
24. Miteva MA, Violas S, Montes M, Gomez D, Tuffery P, Villoutreix BO (2006) FAF-drugs: free adme/tox filtering of compound collections. Nucleic Acids Res 34:W738-W744 (Pubitemid 44529869)
25. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25 (Pubitemid 27046991)
26. Mulabagal V, Calderón AI (2010) Development of an ultrafiltration-liquid chromatography/mass spectrometry (UF-LC/ MS) based ligand-binding assay and an LC/MS based functional assay for Mycobacterium tuberculosis shikimate kinase. Anal Chem 82:3616-3621
27. Huang N, Shoichet BK, Irwin JJ (2006) Benchmarking sets for molecular docking. J Med Chem 49:6789-801 (Pubitemid 44749746)
28. Brooijmans N, Sharp KA, Kuntz ID (2003) Molecular recognition and docking algorithms. Annu Rev Biophys Biomol Struct 32:335-373 (Pubitemid 37056233)
29. Segura-Cabrera A, Rodriguez-Perez MA (2008) Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening. Bioorg Med Chem Lett 18:3152-3157 (Pubitemid 351721011)
30. Kumar M, Verma S, Sharma S, Srinivasan A, Singh TP, Kaur P (2010) Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis. Chem Biol Drug Des 76:277-284
31. Noble ME, Endicott JA, Johnson LN (2004) Protein kinase inhibitors: insights into drug design from structure. Science 303:1800-1805 (Pubitemid 38374863)
32. Canduri F, De Azevedo Jr WF (2005) Structural basis for interaction of inhibitors with cyclin-dependent kinase 2. Curr Comput-Aid Drug 1:53-64
33. Lawrie AM, Noble ME, Tunnah P, Brown NR, Johnson LN, Endicott JA (1997) Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Nat Struct Biol 4:796-801
34. De Azevedo Jr WF, Mueller-Dieckmann HJ, Schulze-Gahmen U, Worland PJ, Sausville E, Kim SH (1996) Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc Natl Acad Sci USA 93:2735-2740 (Pubitemid 26116234)
35. De Azevedo Jr WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH (1997) Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem 243:518-526 (Pubitemid 27060442)
36. Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Prot Eng 8:127-134